Industry / United States
MRSA Spurs New Interest In Antibiotics
March 2008 | Industry NewsAround four antibiotics are set for review by the US FDA in 2008, which suggests that some life is being seen in an area of research that has been overlooked in recent years, according to infectious disease experts. However, the US FDA has asked for more information about a new antibiotic, ceftobiprole, from US-based
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
